Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nicholas A. Iovino
Observed name:
Nicholas Iovino
Institution:
Nationwide Children's Hospital
Observed institutions:
University of Notre Dame,
Nationwide Children's Hospital,
Youngstown State University,
The Ohio State University Wexner Medical Center,
Indiana University South Bend,
Indiana University School of Medicine,
The Ohio State University
show all 7
ORCID:
0000-0001-7611-6294
Observed ORCID:
0000-0001-7611-6294
OpenAlex ID:
A5059802933
Green tea polyphenolic antioxidants oxidize hydrogen sulfide to thiosulfate and polysulfides: A possible new mechanism underpinning their biological action
2020
·
Kenneth R. Olson
, Austin Briggs
, et al.
·
Redox Biology
·
51
PDF
‘Antioxidant’ berries, anthocyanins, resveratrol and rosmarinic acid oxidize hydrogen sulfide to polysulfides and thiosulfate: A novel mechanism underlying their biological actions
2021
·
Kenneth R. Olson
, Yan Gao
, et al.
·
Free Radical Biology and Medicine
·
30
Investigating Eye Movements in Natural Language and C++ Source Code - A Replication Experiment
2017
·
Patrick Peachock
, Nicholas Iovino
, et al.
·
Lecture notes in computer science
·
21
Maternal and Neonatal Hemorrhage From Vitamin K Deficiency in the Setting of Crohn Disease in Pregnancy
2025
·
Sydney Lammers
, Nicholas A. Iovino
, et al.
·
Obstetrics and Gynecology
·
6
Clinical impacts of immunomodulator withdrawal from anti‐tumor necrosis factor combination therapy in pediatric inflammatory bowel disease
2024
·
Nicholas A. Iovino
, Madeline G. McClinchie
, et al.
·
Journal of Pediatric Gastroenterology and Nutrition
·
4
PDF
Induction-phase infliximab monitoring accelerates time to remission in pediatric IBD: a retrospective cohort study
2026
·
Nicholas Iovino
, Samantha R Paglinco
, et al.
·
Crohn s & Colitis 360
Mo1635 EARLY PROACTIVE THERAPEUTIC DRUG MONITORING OF INFLIXIMAB ACCELERATES TIME TO REMISSION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
2026
·
Nicholas Iovino
, Samantha Paglinco
, et al.
·
Gastroenterology
Mo1635 EARLY PROACTIVE THERAPEUTIC DRUG MONITORING OF INFLIXIMAB ACCELERATES TIME TO REMISSION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
2026
·
Nicholas Iovino
, Samantha Paglinco
, et al.
·
Gastrointestinal Endoscopy
Early Proactive Therapeutic Drug Monitoring of Infliximab Accelerates Time to Remission in Children With Inflammatory Bowel Disease
2026
·
Samantha Paglinco
, Nicholas Iovino
, et al.
·
Gastroenterology
Early Proactive Therapeutic Drug Monitoring of Infliximab Accelerates Time to Remission in Children With Inflammatory Bowel Disease
2026
·
Samantha Paglinco
, Nicholas Iovino
, et al.
·
Inflammatory Bowel Diseases
Assessing the Clinical Impacts of Immunomodulatory Withdrawal From Anti-tnf Combination Therapy in Pediatric Inflammtory Bowel Disease
2024
·
Nicholas Iovino
, Brendan Boyle
, et al.
·
Inflammatory Bowel Diseases
PDF
Assessing the Clinical Impacts of Immunomodulatory Withdrawal From Anti-tnf Combination Therapy in Pediatric Inflammtory Bowel Disease
2024
·
Nicholas Iovino
, Brendan Boyle
, et al.
·
Gastroenterology
PDF
Show more works
View as search
Works count:
12
Citation count:
112
H-index:
4
I10-index:
3
Year
Topic
Type